The company has expanded its laboratories in the Virginia Biotechnology Research Park in Richmond, Virginia, by acquiring additional analytical capabilities, including advanced spectroscopy tools and ...

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio” or the "Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, ...

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, ...

Thursday, Piper Sandler reiterated an Overweight rating on BridgeBio Pharma (NASDAQ:BBIO) with a price target of $46.00, aligning with the broader Wall Street sentiment. According to InvestingPro data ...

Thursday, Piper Sandler reiterated an Overweight rating on BridgeBio Pharma (NASDAQ:BBIO) with a price target of $46.00, aligning with the broader Wall Street sentiment. According to InvestingPro ...

Ginkgo Bioworks announced a new contract with the Advanced Research Projects Agency for Health (ARPA-H), alongside partners Tritica Biosciences, US Pharmacopeia (USP), On Demand Pharmaceuticals, and ...

TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Wednesday reported a loss of $6.7 million in its fourth quarter. The Toronto-based company said it had a loss of $2.15 per share.

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain operations in order to meet growing demand from the biopharma industry.

For commercial teams, approval is the starting gun, not the finish line. Biopharma firms are now operating in a compressed commercial window. Pricing scrutiny is intensifying, regulatory environments ...

The facility also marks the debut of a new manufacturing execution system, replacing legacy systems and setting a template for other plants worldwide. Robotics for Safety and Inspection Novelis is ...

As the mar­kets con­tin­ued to fall Mon­day in re­sponse to the Trump ad­min­is­tra­tion’s tar­iff pro­pos­als, biotech has par­tic­u­lar­ly been hit hard. The … ...